GLENMARK PHARMACEUTICALS
|
GLENMARK PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹1,399 Cr | ₹569 Cr | ₹868 Cr | ₹1,441 Cr | ₹1,382 Cr |
| Adjustment | ₹982 Cr | ₹1,010 Cr | ₹1,472 Cr | ₹787 Cr | ₹645 Cr |
| Changes In working Capital | ₹-2,529 Cr | ₹-797 Cr | ₹-1,074 Cr | ₹-561 Cr | ₹-386 Cr |
| Cash Flow after changes in Working Capital | ₹-147 Cr | ₹782 Cr | ₹1,266 Cr | ₹1,667 Cr | ₹1,641 Cr |
| Cash Flow from Operating Activities | ₹-828 Cr | ₹-265 Cr | ₹625 Cr | ₹1,109 Cr | ₹1,131 Cr |
| Cash Flow from Investing Activities | ₹2.09 Cr | ₹4,561 Cr | ₹-528 Cr | ₹-333 Cr | ₹-675 Cr |
| Cash Flow from Financing Activities | ₹787 Cr | ₹-3,906 Cr | ₹-77 Cr | ₹-520 Cr | ₹-442 Cr |
| Net Cash Inflow / Outflow | ₹-38 Cr | ₹389 Cr | ₹19 Cr | ₹255 Cr | ₹14 Cr |
| Opening Cash & Cash Equivalents | ₹1,658 Cr | ₹1,443 Cr | ₹1,411 Cr | ₹1,138 Cr | ₹1,110 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | ₹0.67 Cr | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | ₹-192 Cr | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹56 Cr | ₹18 Cr | ₹12 Cr | ₹18 Cr | ₹14 Cr |
| Closing Cash & Cash Equivalent | ₹1,676 Cr | ₹1,658 Cr | ₹1,443 Cr | ₹1,411 Cr | ₹1,138 Cr |
Compare Cashflow Statement of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹56,179.0 Cr | 0.3% | 5.8% | 29.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.9% | -1.8% | -2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | 2.1% | 0.2% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | 0.5% | 2.2% | 11.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | 0.7% | -0.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | -0.1% | 2.5% | 2.5% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 0.3% |
5.8% |
29.2% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses